Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Profit After Tax (2016 - 2025)

Traws Pharma (TRAW) has disclosed Profit After Tax for 14 consecutive years, with -$7.4 million as the latest value for Q4 2025.

  • For Q4 2025, Profit After Tax rose 75.13% year-over-year to -$7.4 million; the TTM value through Dec 2025 reached $9.2 million, up 105.51%, while the annual FY2025 figure was $9.2 million, 105.51% up from the prior year.
  • Profit After Tax hit -$7.4 million in Q4 2025 for Traws Pharma, down from -$4.0 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $21.5 million in Q1 2025 and bottomed at -$123.1 million in Q2 2024.
  • Average Profit After Tax over 5 years is -$10.6 million, with a median of -$4.5 million recorded in 2021.
  • Year-over-year, Profit After Tax tumbled 2797.48% in 2024 and then surged 531.27% in 2025.
  • Traws Pharma's Profit After Tax stood at -$3.8 million in 2021, then crashed by 44.0% to -$5.4 million in 2022, then rose by 22.8% to -$4.2 million in 2023, then plummeted by 615.15% to -$29.9 million in 2024, then surged by 75.13% to -$7.4 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$7.4 million, -$4.0 million, and -$915000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.